Efficacy News and Research

RSS
Phytomedics awarded $244,000 QTDP grant for development of RA drug

Phytomedics awarded $244,000 QTDP grant for development of RA drug

ARIAD reports $20.4 million net loss for third quarter 2010

ARIAD reports $20.4 million net loss for third quarter 2010

Provectus holds second meeting with Australian TGA to review approval of PV-10 for metastatic melanoma

Provectus holds second meeting with Australian TGA to review approval of PV-10 for metastatic melanoma

Discovery Labs reports net operating loss of $6.2 million for third quarter 2010

Discovery Labs reports net operating loss of $6.2 million for third quarter 2010

Angiotech reports $59.0 million total revenue for third quarter 2010

Angiotech reports $59.0 million total revenue for third quarter 2010

Fake antimalarial medications uncovered across Ghana

Fake antimalarial medications uncovered across Ghana

Arena and Eisai report positive results from lorcaserin BLOOM-DM trial in obese, overweight diabetics

Arena and Eisai report positive results from lorcaserin BLOOM-DM trial in obese, overweight diabetics

Arena third quarter net loss increases to $36.3 million

Arena third quarter net loss increases to $36.3 million

S.A.N.E. Vax calls for federal approval of reliable HPV genotyping test in cervical cancer prevention programs

S.A.N.E. Vax calls for federal approval of reliable HPV genotyping test in cervical cancer prevention programs

ORAL Solo Phase 3 study shows tasocitinib reduces signs and symptoms of active RA

ORAL Solo Phase 3 study shows tasocitinib reduces signs and symptoms of active RA

ORVACS launches ERAMUNE 01 Phase II study to decrease HIV viral reservoirs

ORVACS launches ERAMUNE 01 Phase II study to decrease HIV viral reservoirs

Genta commences tesetaxel Phase 2b clinical trial as 1st-line chemotherapy for metastatic breast cancer

Genta commences tesetaxel Phase 2b clinical trial as 1st-line chemotherapy for metastatic breast cancer

SIMPONI injection improves inflammation, structural damage in RA patients

SIMPONI injection improves inflammation, structural damage in RA patients

Dabigatran etexilate benefits AF patients with previous stroke or transient ischemic attack

Dabigatran etexilate benefits AF patients with previous stroke or transient ischemic attack

EpiCept third quarter net loss decreases to $3.2 million

EpiCept third quarter net loss decreases to $3.2 million

Women prefer silicone implants after double mastectomy

Women prefer silicone implants after double mastectomy

BioCryst to present data on BCX4208 for gout at ACR Scientific Meeting

BioCryst to present data on BCX4208 for gout at ACR Scientific Meeting

New data on Soliris for PNH treatment to be presented at ASH Annual Meeting

New data on Soliris for PNH treatment to be presented at ASH Annual Meeting

Fuisz receives U.S. Patent for new generation of glucose, analyte analyzers

Fuisz receives U.S. Patent for new generation of glucose, analyte analyzers

NUVO announces positive results from WF10 Phase 2 clinical trial for severe allergic rhinitis

NUVO announces positive results from WF10 Phase 2 clinical trial for severe allergic rhinitis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.